English

AAIPHARMA INC

EDGAR

Current report amendment (8-K/A) · filed 2005-11-09

46 filing records in this dataset, filed from 1996-11-14 to 2005-11-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

43.2 million USD

2004-09-30 · USD

Exact inputs and evidence

Revenue: 43219000 USD Source

Operating margin

-45.03%

2004-09-30 · %

Exact inputs and evidence

Operating Income: -19463000 USD Source
Revenue: 43219000 USD Source

Operating cash flow

-16.3 million USD

2004-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -65578000 USD Source
Operating Cash Flow: -49287000 USD Source

Free cash flow

-17 million USD

2004-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -65578000 USD Source
Operating Cash Flow: -49287000 USD Source
Capital Expenditure: 5475000 USD Source
Capital Expenditure: 4719000 USD Source

Cash and cash equivalents: 4.47 million USD 2005-09-30 Source
Exact value

4471000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2005-11-09.

Financial data available through: 2003-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2003-12-31
Operating income: 10 of 11 periods available· newest 2003-12-31
Net income: 10 of 11 periods available· newest 2003-12-31
Operating cash flow: 5 of 11 periods available· newest 2003-12-31
Capital expenditure: 5 of 11 periods available· newest 2003-12-31
Total assets: 4 of 11 periods available· newest 2003-12-31
liabilities: No compatible figures in this window
Current assets: 4 of 11 periods available· newest 2003-12-31
Current liabilities: 4 of 11 periods available· newest 2003-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2003-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-2.4%

Prior period

USD 230.51 million

2002-01-01 – 2002-12-31
Current period

USD 224.98 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

224977000 − 230510000 = -5533000 USD

230510000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
224977000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · AAIPHARMA INC · 2003-12-31 AAIPHARMA INC (edgar:1013243) Year-over-year change in Revenue: -5533000 USD Concept: fundies:Revenue Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 224977000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-04-006287.txt#12807 Input fundies:Revenue: 230510000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-04-006287.txt#12807
The citation records this snapshot. The page link may show a newer release later.
Net income
-349.3%

Prior period

USD 13.12 million

2002-01-01 – 2002-12-31
Current period

−USD 32.7 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

-32703000 − 13118000 = -45821000 USD

13118000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
-32703000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AAIPHARMA INC · 2003-12-31 AAIPHARMA INC (edgar:1013243) Year-over-year change in Net income: -45821000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -32703000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#16373 Input fundies:NetIncome: 13118000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#16373
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+23.9%

Prior period

USD 30.97 million

2002-01-01 – 2002-12-31
Current period

USD 38.35 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

38352000 − 30965000 = 7387000 USD

30965000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
38352000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AAIPHARMA INC · 2003-12-31 AAIPHARMA INC (edgar:1013243) Year-over-year change in Operating cash flow: 7387000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 38352000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#14768 Input fundies:OperatingCashFlow: 30965000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#14768
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+39.6%

Prior period

USD 8.53 million

2002-01-01 – 2002-12-31
Current period

USD 11.91 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

11910000 − 8529000 = 3381000 USD

8529000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
11910000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · AAIPHARMA INC · 2003-12-31 AAIPHARMA INC (edgar:1013243) Year-over-year change in Capital expenditure: 3381000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 11910000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#14810 Input fundies:CapitalExpenditure: 8529000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#14810
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2003 2003-01-01 – 2003-12-31

Revenue USD 224.98 million 100% of revenue
Operating costs Derived USD 246.29 million 109% of revenue
Operating income −USD 21.31 million −9.5% of revenue
Tax, interest and other Derived USD 11.39 million 5.1% of revenue
Net income −USD 32.7 million −15% of revenue

Cash

Operating cash flow USD 38.35 million 17% of revenue
Capital expenditure USD 11.91 million 5.3% of revenue
Free cash flow Derived USD 26.44 million 12% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 Net loss: net income was −0.4% of revenue.
2001 91%
2002 15%79%
2003 Operating loss: operating costs were 109% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 2000-01-01 – 2000-12-31	104245000	102211000 Derived	2034000	2436000 Derived	-402000	Unavailable	Source 2000-01-01 – 2000-12-31: 104245000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: 2034000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -402000 USD Inspect Net Income Open source
2001 2001-01-01 – 2001-12-31	141073000	127844000 Derived	13229000	7289000 Derived	5940000	Unavailable	Source 2001-01-01 – 2001-12-31: 141073000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: 13229000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: 5940000 USD Inspect Net Income Open source
2002 2002-01-01 – 2002-12-31	230510000	181892000 Derived	48618000	35500000 Derived	13118000	22436000 Derived	Source 2002-01-01 – 2002-12-31: 230510000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: 48618000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: 13118000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 30965000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 8529000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	224977000	246290000 Derived	-21313000	11390000 Derived	-32703000	26442000 Derived	Source 2003-01-01 – 2003-12-31: 224977000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -21313000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -32703000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 38352000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 11910000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 225M 2003

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Revenue	104245000	Revenue: 104245000 Open source
20012001-12-31	Revenue	141073000	Revenue: 141073000 Open source
20022002-12-31	Revenue	230510000	Revenue: 230510000 Open source
20032003-12-31	Revenue	224977000	Revenue: 224977000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-2.4% 2003

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Year over year	No prior comparable period	Revenue: 104245000 Open source
20012001-12-31	Year over year	35.3%	Revenue: 141073000 Open source Revenue: 104245000 Open source
20022002-12-31	Year over year	63.4%	Revenue: 230510000 Open source Revenue: 141073000 Open source
20032003-12-31	Year over year	-2.4%	Revenue: 224977000 Open source Revenue: 230510000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -9.5% 2003

Net margin -14.5% 2003

Free cash flow margin 11.8% 2003

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Operating margin	2%	Operating Income: 2034000 Open source Revenue: 104245000 Open source
20012001-12-31	Operating margin	9.4%	Operating Income: 13229000 Open source Revenue: 141073000 Open source
20022002-12-31	Operating margin	21.1%	Operating Income: 48618000 Open source Revenue: 230510000 Open source
20032003-12-31	Operating margin	-9.5%	Operating Income: -21313000 Open source Revenue: 224977000 Open source
20002000-12-31	Net margin	-0.4%	Net Income: -402000 Open source Revenue: 104245000 Open source
20012001-12-31	Net margin	4.2%	Net Income: 5940000 Open source Revenue: 141073000 Open source
20022002-12-31	Net margin	5.7%	Net Income: 13118000 Open source Revenue: 230510000 Open source
20032003-12-31	Net margin	-14.5%	Net Income: -32703000 Open source Revenue: 224977000 Open source
20002000-12-31	Free cash flow margin	Not reported	Revenue: 104245000 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 141073000 Open source
20022002-12-31	Free cash flow margin	9.7%	Revenue: 230510000 Open source Operating Cash Flow: 30965000 Open source Capital Expenditure: 8529000 Open source
20032003-12-31	Free cash flow margin	11.8%	Revenue: 224977000 Open source Operating Cash Flow: 38352000 Open source Capital Expenditure: 11910000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 38.4M 2003

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Operating cash flow	Not reported	No source recorded
20012001-12-31	Operating cash flow	Not reported	No source recorded
20022002-12-31	Operating cash flow	30965000	Operating Cash Flow: 30965000 Open source
20032003-12-31	Operating cash flow	38352000	Operating Cash Flow: 38352000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 26.4M 2003

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20002000-12-31	Free cash flow	Unavailable	No source recorded
20012001-12-31	Free cash flow	Unavailable	No source recorded
20022002-12-31	Free cash flow	22436000	Operating Cash Flow: 30965000 Open source Capital Expenditure: 8529000 Open source
20032003-12-31	Free cash flow	26442000	Operating Cash Flow: 38352000 Open source Capital Expenditure: 11910000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2000-12-31	Liabilities / assets	Not reported	Total Assets: 112151000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 196286000 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 433502000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 534597000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.88× 2003

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20002000-12-31	Current assets / current liabilities	1.24×	Current Assets: 54877000 Open source Current Liabilities: 44319000 Open source
20012001-12-31	Current assets / current liabilities	1.54×	Current Assets: 58458000 Open source Current Liabilities: 37965000 Open source
20022002-12-31	Current assets / current liabilities	1.28×	Current Assets: 71151000 Open source Current Liabilities: 55794000 Open source
20032003-12-31	Current assets / current liabilities	0.88×	Current Assets: 98177000 Open source Current Liabilities: 111137000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	USD 2.2 million Exact value Exact value: 2196000 USD 1994-01-01 – 1994-12-31: 2196000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AAIPHARMA INC · 1994-12-31 AAIPHARMA INC (edgar:1013243) Net Income: 2196000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2196000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3685 The citation records this snapshot. The page link may show a newer release later.	USD 4.9 million Exact value Exact value: 4901000 USD 1994-01-01 – 1994-12-31: 4901000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AAIPHARMA INC · 1994-12-31 AAIPHARMA INC (edgar:1013243) Operating Cash Flow: 4901000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4901000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3701 The citation records this snapshot. The page link may show a newer release later.	USD 3.09 million Exact value Exact value: 3091000 USD 1994-01-01 – 1994-12-31: 3091000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AAIPHARMA INC · 1994-12-31 AAIPHARMA INC (edgar:1013243) Capital Expenditure: 3091000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3091000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3704 The citation records this snapshot. The page link may show a newer release later.	USD 1.81 million Calculation and evidence 4901000 − 3091000 USD Exact free cash flow: 1810000 USD 1994-01-01 – 1994-12-31: 4901000 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 3091000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AAIPHARMA INC · 1994-12-31 AAIPHARMA INC (edgar:1013243) Free cash flow: 1810000 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4901000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3701 Input fundies:CapitalExpenditure: 3091000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3704 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	USD 3.25 million Exact value Exact value: 3245000 USD 1995-01-01 – 1995-12-31: 3245000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AAIPHARMA INC · 1995-12-31 AAIPHARMA INC (edgar:1013243) Net Income: 3245000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3245000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-98-004347.txt#1595 The citation records this snapshot. The page link may show a newer release later.	USD 3.81 million Exact value Exact value: 3811000 USD 1995-01-01 – 1995-12-31: 3811000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AAIPHARMA INC · 1995-12-31 AAIPHARMA INC (edgar:1013243) Operating Cash Flow: 3811000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3811000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3701 The citation records this snapshot. The page link may show a newer release later.	USD 1.72 million Exact value Exact value: 1720000 USD 1995-01-01 – 1995-12-31: 1720000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AAIPHARMA INC · 1995-12-31 AAIPHARMA INC (edgar:1013243) Capital Expenditure: 1720000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1720000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3704 The citation records this snapshot. The page link may show a newer release later.	USD 2.09 million Calculation and evidence 3811000 − 1720000 USD Exact free cash flow: 2091000 USD 1995-01-01 – 1995-12-31: 3811000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 1720000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AAIPHARMA INC · 1995-12-31 AAIPHARMA INC (edgar:1013243) Free cash flow: 2091000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3811000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3701 Input fundies:CapitalExpenditure: 1720000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3704 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 3.15 million Exact value Exact value: -3148000 USD 1996-01-01 – 1996-12-31: -3148000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AAIPHARMA INC · 1996-12-31 AAIPHARMA INC (edgar:1013243) Net Income: -3148000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3148000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-99-003871.txt#9219 The citation records this snapshot. The page link may show a newer release later.	USD 2.37 million Exact value Exact value: 2367000 USD 1996-01-01 – 1996-12-31: 2367000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AAIPHARMA INC · 1996-12-31 AAIPHARMA INC (edgar:1013243) Operating Cash Flow: 2367000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2367000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3701 The citation records this snapshot. The page link may show a newer release later.	USD 7.61 million Exact value Exact value: 7609000 USD 1996-01-01 – 1996-12-31: 7609000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AAIPHARMA INC · 1996-12-31 AAIPHARMA INC (edgar:1013243) Capital Expenditure: 7609000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7609000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3704 The citation records this snapshot. The page link may show a newer release later.	−USD 5.24 million Calculation and evidence 2367000 − 7609000 USD Exact free cash flow: -5242000 USD 1996-01-01 – 1996-12-31: 2367000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 7609000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AAIPHARMA INC · 1996-12-31 AAIPHARMA INC (edgar:1013243) Free cash flow: -5242000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2367000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3701 Input fundies:CapitalExpenditure: 7609000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-97-003450.txt#3704 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	USD 2.5 million Exact value Exact value: 2498000 USD 1997-01-01 – 1997-12-31: 2498000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AAIPHARMA INC · 1997-12-31 AAIPHARMA INC (edgar:1013243) Net Income: 2498000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2498000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-00-004215.txt#1463 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1998 1998-01-01 – 1998-12-31	USD 6.54 million Exact value Exact value: 6538000 USD 1998-01-01 – 1998-12-31: 6538000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AAIPHARMA INC · 1998-12-31 AAIPHARMA INC (edgar:1013243) Net Income: 6538000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 6538000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-01-004644.txt#2942 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1999 1999-01-01 – 1999-12-31	−USD 7.91 million Exact value Exact value: -7913000 USD 1999-01-01 – 1999-12-31: -7913000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AAIPHARMA INC · 1999-12-31 AAIPHARMA INC (edgar:1013243) Net Income: -7913000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7913000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-02-002175.txt#3412 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2000 2000-01-01 – 2000-12-31	−USD 402,000 Exact value Exact value: -402000 USD 2000-01-01 – 2000-12-31: -402000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AAIPHARMA INC · 2000-12-31 AAIPHARMA INC (edgar:1013243) Net Income: -402000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -402000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-03-004083.txt#9304 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2001 2001-01-01 – 2001-12-31	USD 5.94 million Exact value Exact value: 5940000 USD 2001-01-01 – 2001-12-31: 5940000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AAIPHARMA INC · 2001-12-31 AAIPHARMA INC (edgar:1013243) Net Income: 5940000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5940000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-04-006287.txt#13262 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	USD 13.12 million Exact value Exact value: 13118000 USD 2002-01-01 – 2002-12-31: 13118000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AAIPHARMA INC · 2002-12-31 AAIPHARMA INC (edgar:1013243) Net Income: 13118000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: 13118000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#16373 The citation records this snapshot. The page link may show a newer release later.	USD 30.97 million Exact value Exact value: 30965000 USD 2002-01-01 – 2002-12-31: 30965000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AAIPHARMA INC · 2002-12-31 AAIPHARMA INC (edgar:1013243) Operating Cash Flow: 30965000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 30965000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#14768 The citation records this snapshot. The page link may show a newer release later.	USD 8.53 million Exact value Exact value: 8529000 USD 2002-01-01 – 2002-12-31: 8529000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AAIPHARMA INC · 2002-12-31 AAIPHARMA INC (edgar:1013243) Capital Expenditure: 8529000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8529000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#14810 The citation records this snapshot. The page link may show a newer release later.	USD 22.44 million Calculation and evidence 30965000 − 8529000 USD Exact free cash flow: 22436000 USD 2002-01-01 – 2002-12-31: 30965000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 8529000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AAIPHARMA INC · 2002-12-31 AAIPHARMA INC (edgar:1013243) Free cash flow: 22436000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 30965000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#14768 Input fundies:CapitalExpenditure: 8529000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#14810 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 32.7 million Exact value Exact value: -32703000 USD 2003-01-01 – 2003-12-31: -32703000 USD Inspect Net Income Open source Share or cite Citation for Net Income · AAIPHARMA INC · 2003-12-31 AAIPHARMA INC (edgar:1013243) Net Income: -32703000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32703000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#16373 The citation records this snapshot. The page link may show a newer release later.	USD 38.35 million Exact value Exact value: 38352000 USD 2003-01-01 – 2003-12-31: 38352000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AAIPHARMA INC · 2003-12-31 AAIPHARMA INC (edgar:1013243) Operating Cash Flow: 38352000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 38352000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#14768 The citation records this snapshot. The page link may show a newer release later.	USD 11.91 million Exact value Exact value: 11910000 USD 2003-01-01 – 2003-12-31: 11910000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AAIPHARMA INC · 2003-12-31 AAIPHARMA INC (edgar:1013243) Capital Expenditure: 11910000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11910000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#14810 The citation records this snapshot. The page link may show a newer release later.	USD 26.44 million Calculation and evidence 38352000 − 11910000 USD Exact free cash flow: 26442000 USD 2003-01-01 – 2003-12-31: 38352000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 11910000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AAIPHARMA INC · 2003-12-31 AAIPHARMA INC (edgar:1013243) Free cash flow: 26442000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:29:20Z Snapshot: 18aa549422a3d2c4e7396898aae8ddf30d8f56d6f5116283d5e1c8e0c6ec13da Dimensions: Consolidated View: https://fundies.io/companies/edgar/1013243?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 38352000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#14768 Input fundies:CapitalExpenditure: 11910000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1013243/0000950144-05-004448.txt#14810 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

46 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001013243, 1013243, edgar:1013243

Also known as APPLIED ANALYTICAL INDUSTRIES INC

AAIPHARMA INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2003 2003-01-01 – 2003-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation